Diabetes Discourse
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease.
Because when it comes to diabetes, glucose control is just the beginning.
1-15 of 219
Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
Diabetes DiscourseAddressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
John W. Ostrominski, MD, MPH
Enhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Diabetes DiscourseEnhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Laura Chiavaroli, PhD
Investigating Beta Cell Dysfunction and Immune Activity in Early T1D
Diabetes DiscourseInvestigating Beta Cell Dysfunction and Immune Activity in Early T1D
Edward Phelps, PhD
Investigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Diabetes DiscourseInvestigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Vira Kravets, PhD
Unanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Diabetes DiscourseUnanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Edward Phelps, PhD
Survodutide in Obesity: Insights from SYNCHRONIZE-1
Diabetes DiscourseSurvodutide in Obesity: Insights from SYNCHRONIZE-1
Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD
- advertisement
Addressing Cost-Related Medication Non-Adherence in Diabetes
Diabetes DiscourseAddressing Cost-Related Medication Non-Adherence in Diabetes
Kimberly Narain, MD, MPH, PhD
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes DiscourseUnderstanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
Digital Innovation in Diabetes Prevention for Older Adults
Diabetes DiscourseDigital Innovation in Diabetes Prevention for Older Adults
Steve Jackson, PharmD
Souptik Barua, PhD
Emily Johnston, MPH, PhD
Incretin-Based Advances in Obesity and T2D Care
Diabetes DiscourseIncretin-Based Advances in Obesity and T2D Care
Javier Morales, MD, FACP, FACE
Addressing Unmet Needs in Type 1 Diabetes Management
Diabetes DiscourseAddressing Unmet Needs in Type 1 Diabetes Management
Javier Morales, MD, FACP, FACE
Diabetes and CKD: Strategies for Diagnosis and Treatment
Diabetes DiscourseDiabetes and CKD: Strategies for Diagnosis and Treatment
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ian de Boer, MD
- advertisement
Uncovering the Prevalence of Type 1 Diabetes in Older Adults
Diabetes DiscourseUncovering the Prevalence of Type 1 Diabetes in Older Adults
Elena Toschi, MD
Concentrating on the MOMPOD Trial for Metformin Plus Insulin
Diabetes DiscourseConcentrating on the MOMPOD Trial for Metformin Plus Insulin
John Buse, MD, PhD
Kim Boggess, MD
Utilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
Diabetes DiscourseUtilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
R. Paul Wadwa, M.D.